Product
THR-687
1 clinical trial
3 indications
Indication
Diabetes MellitusIndication
Diabetic RetinopathyIndication
Diabetic Macular EdemaClinical trial
A Phase 2, Randomised, Multicentre Study to Assess the Dose Level of Multiple THR-687 Injections and to Evaluate the Efficacy and Safety of THR-687 Versus Aflibercept for the Treatment of Diabetic Macular Oedema (DME)Status: Terminated, Estimated PCD: 2022-06-29